Inhibition of epithelial to mesenchymal transition by e-cadherin up-regulation via repression of slug transcription and inhibition of e-cadherin degradation dual role of scaffold/matrix attachment region-binding protein 1 (smar1) in breast cancer cells

Journal of Biological Chemistry

Volumn 289, Issue 37, 2014, Pages 25431-25444

  Adhikary, Arghya ^a   Chakraborty, Samik ^a   Mazumdar, Minakshi ^a   Ghosh, Swatilekha ^a   Mukherjee, Shravanti ^a   Manna, Argha ^a   Mohanty, Suchismita ^a   Nakka, Kiran Kumar ^b   Joshi, Shruti ^b   De, Abhijit ^c   Chattopadhyay, Samit ^b   Sa, Gaurisankar ^a   Das, Tanya ^a  

^a BOSE INSTITUTE   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; GLYCOPROTEINS; PATHOLOGY; PROTEINS; TRANSCRIPTION;

BINDING PROTEINS; BREAST CANCER; BREAST CANCER CELLS; EPITHELIAL TO MESENCHYMAL TRANSITIONS; EPITHELIAL-MESENCHYMAL TRANSITION; POTENTIAL MECHANISM; TUMOR METASTASIS; UP-REGULATION;

SCAFFOLDS (BIOLOGY);

BINDING PROTEIN; HISTONE DEACETYLASE 1; PROTEIN MDM2; SCAFFOLD MATRIX ATTACHMENT REGION BINDING PROTEIN 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; BANP PROTEIN, HUMAN; CADHERIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; HDAC1 PROTEIN, HUMAN; MDM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MATRIX ATTACHMENT REGION; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TUMOR INVASION; UBIQUITINATION; UPREGULATION; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CADHERINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; DNA-BINDING PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE 1; HUMANS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTION FACTORS;

EID: 84907163267     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.527267     Document Type: Article

References (40)

1. Adhikary, A., Mohanty, S., Lahiry, L., Hossain, D. M. S., Chakraborty, S., and Das, T. (2010) Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk. Febs. Lett. 584, 7-14
2. Steeg, P. S. (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nature Med. 12, 895-904
3. Savagner, P. (2001) Leaving the neighbourhood: molecular mechanisms involved during epithelial-mesenchymal transition. BioEssays 23, 912-923
4. Huber, M. A., Kraut, N., and Beug, H. (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Op. Cell Biol. 17, 548-558
5. Thiery, J. P. (2002) Epithelial-mesenchymal transition in tumor progression. Nat. Rev. Cancer 2, 442-454
6. Mareel, M., and Leroy, A. (2003) Clinical, cellular and molecular aspects of cancer invasion. Physiol. Rev. 83, 337-376
7. Bremnes, R. M. (2002) High-throughput microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in small cell lung cancer. J. Clin. Oncol. 20, 2417-2428
8. Frixen, U. H. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113, 173-185
9. Nieto, M. A. (2002) The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol. 3, 155-166
10. Bolós, V., Peinado, H., Pérez-Moreno, M. A., Fraga, M. F., Esteller, M., and Cano, A. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 116, 499-511
11. Hajra, K. M., Chen, D. Y., and Fearon, E. R. (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62, 1613-1618
12. Yang, J. Y., Zong, C. S., Xia, W., Wei, Y., Ali-Seyed, M., Li, Z., Broglio, K., Berry, D. A., and Hung, M. C. (2006) MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol. Cell Biol. 26, 7269-7282
13. Iwakuma, T., and Lozano, G. (2003) MDM2, an introduction. Mol. Cancer Res. 1, 993-1000
14. Mathew, R., Arora, S., Khanna, R., Mathur, M., Shukla, N. K., and Ralhan, R. (2002). Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer. Eur. J. Cancer 38, 832-841
15. Lukas, J., Gao, D. Q., Keshmeshian, M., Wen, W. H., Tsao-Wei, D., Rosenberg, S., and Press, M. F. (2001). Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res. 61, 3212-3219
16. Sen, G. S., Mohanty, S., Hossain, D. M. S., Bhattacharyya, S., Banerjee, S., Chakraborty, J., Saha S., Ray, P., Bhattacharjee, P., Mandal, D., Bhattacharya, A., Chattopadhyay, S., Das, T., and Sa, G. (2011) Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favour of p53-p300 in breast cancer. J. Biol. Chem. 286, 42232-42247
17. Pavithra, L., Mukherjee, S., Sreenath, K., Kar, S., Sakaguchi, K., Roy, S., and Chattopadhyay, S. (2009) SMAR1 forms a ternary complex with p53- MDM2 and negatively regulates p53-mediated transcription. J. Mol. Biol. 388, 691-702
18. Heng, H. H., Goetze, S., Ye, C. J., Liu, G., Stevens, J. B., Bremer, S. W., Bode, J., Wykes, S. M., and Krawetz, S. A. (2004) Chromatin loops are selectively anchored using Scaffold/Matrix attachment regions. J. Cell Sci. 117, 999-1008
19. Jenuwein, T., Forrester, W. C., Fernández-Herrero, L. A., Laible, G., Dull, M., and Grosschedl, R. (1997) Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 385, 269-272
20. Rampalli, S., Pavithra, L., Bhatt, A., Kundu, T. K., and Chattopadhyay, S. (2005) Tumor suppressor SMAR1 mediates Cyclin D1 repression by recruitment of the SIN3/Histone Deacetylase 1 complex. Mol. Cell Biol. 25, 8415-8429
21. Singh, K., Mogare, D., Giridharagopalan, R. O., Gogiraju, R., Pande, G., and Chattopadhyay, S. (2007) p53 Target Gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion. PLoS ONE 2, e660
22. Moll, U. M., and Petrenko, O. (2003) The MDM2-p53 interaction. Mol. Cancer Res. 1, 1001-1008
23. Chattopadhyay, S., Kaul, R., Charest, A., Housman, D., and Chen, J. (2000) SMAR1, a novel, alternatively spliced gene product, binds the Scaffold/ Matrix-associated region at the T cell receptor beta locus. Genomics 68, 93-96
24. Hsieh, C. Y., Tsai, P. C., Tseng, C. H., Chen, Y. L., Chang, L. S., and Lin, S. R. (2013) Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5- dione blocks migration and invasion of MDA-MB-231 cells. Toxicol. In Vitro 27, 1-10
25. Vergara, D., Valente, C. M., Tinelli, A., Siciliano, C., Lorusso, V., Acierno, R. Giovinazzo, G., Santino, A., Storelli, C., and Maffia, M. (2011) Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer Lett. 310, 1-8
26. Cheng, J. C., Chang, H. M., and Leung, P. C. (2013) Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells. Oncogene 32, 1042-1049
27. Kang, Y., and Massagué, J. (2004) Epithelial-Mesenchymal Transitions: Twist in Development and Metastasis. Cell 118, 277-279
28. Halbleib, J. M., and Nelson, W. J. (2006) Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev. 20, 3199-3214
29. Momand, J., Jung, D., Wilczynski, S., and Niland, J. (1998) The MDM2 gene amplification database. Nucleic Acids Res. 26, 3453-3459
30. Strathdee, G. (2002) Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol. 12, 373-379
31. Batlle, E., Sancho, E., Francí, C., Domínquez, D., Monfar, M., Baulida, J., and García De Herreros, A. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2, 84-89
32. Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., and van Roy, F. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267-1278
33. Bryant, D. M., and Stow, J. L. (2004) The ins and outs of E-cadherin trafficking. Trends Cell Biol. 14, 427-434
34. Singh, K., Sinha, S., Malonia, S. K., Bist, P., Tergaonkar, V., and Chattopadhyay, S. (2009) Tumor suppressor SMAR1 represses IκBα expression and inhibits p65 transactivation through matrix attachment regions. J. Biol. Chem. 284, 1267-1278
35. Bode, J., Benham, C., Knopp, A., and Mielke, C. (2000) Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit. Rev. Eukaryot. Gene Expr. 10, 73-90
36. Blasquez, V. C., Sperry, A. O., Cockerill, P. N., and Garrard, W. T. (1989) Protein: DNA interactions at chromosomal loop attachment sites. Genome. 31, 503-509
37. Lu, Z., Jiang, G., Blume-Jensen, P., and Hunter, T. (2001) Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase. Mol. Cell Biol. 21, 4016-4031
38. Rosen, E. M., and Goldberg, I. D. (1989) Protein factors which regulate cell motility. In vitro Cell Dev. Biol. 25, 1079-1087
39. Wendt, M. K., Smith, J. A., and Schiemann, W. P. (2010) Transforming growth factor beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor dependent breast cancer progression. Oncogene 29, 6485-6498
40. Sinha, S., Malonia, S. K., Mittal, S. P., Singh, K., Kadreppa, S., Kamat, R., Mukhopadhyaya, R., Pal, J. K., Chattopadhyay, S. (2010) Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element. EMBO. J. 29, 830-842